Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
Saved in:
| Title: | Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. |
|---|---|
| Authors: | Christine CW; (San Francisco)., Richardson RM; (Cambridge, MA)., Van Laar A; (Chapel Hill, NC)., Fine EM; (Waltham, MA)., Khwaja OS; (Basel, Switzerland)., Liang GS; (San Diego)., Bankiewicz K; (San Francisco)., Larson PS; (Tucson). |
| Source: | Neurology [Neurology] 2022 Aug 09; Vol. 99 (6), pp. 260-261. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35940892 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Christine+CW%22">Christine CW</searchLink>; (San Francisco).<br /><searchLink fieldCode="AU" term="%22Richardson+RM%22">Richardson RM</searchLink>; (Cambridge, MA).<br /><searchLink fieldCode="AU" term="%22Van+Laar+A%22">Van Laar A</searchLink>; (Chapel Hill, NC).<br /><searchLink fieldCode="AU" term="%22Fine+EM%22">Fine EM</searchLink>; (Waltham, MA).<br /><searchLink fieldCode="AU" term="%22Khwaja+OS%22">Khwaja OS</searchLink>; (Basel, Switzerland).<br /><searchLink fieldCode="AU" term="%22Liang+GS%22">Liang GS</searchLink>; (San Diego).<br /><searchLink fieldCode="AU" term="%22Bankiewicz+K%22">Bankiewicz K</searchLink>; (San Francisco).<br /><searchLink fieldCode="AU" term="%22Larson+PS%22">Larson PS</searchLink>; (Tucson). – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220401060%22">Neurology</searchLink> [Neurology] 2022 Aug 09; Vol. 99 (6), pp. 260-261. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0401060 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1526-632X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200283878%22">00283878 </searchLink><i>NLM ISO Abbreviation: </i>Neurology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35940892 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1212/WNL.0000000000201005 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 260 Titles: – TitleFull: Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Christine CW – PersonEntity: Name: NameFull: Richardson RM – PersonEntity: Name: NameFull: Van Laar A – PersonEntity: Name: NameFull: Fine EM – PersonEntity: Name: NameFull: Khwaja OS – PersonEntity: Name: NameFull: Liang GS – PersonEntity: Name: NameFull: Bankiewicz K – PersonEntity: Name: NameFull: Larson PS IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 08 Text: 2022 Aug 09 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1526-632X Numbering: – Type: volume Value: 99 – Type: issue Value: 6 Titles: – TitleFull: Neurology Type: main |
| ResultId | 1 |